{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:38:09Z","timestamp":1786538289716,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Institute for Information & Communications Technology Planning & Evaluation","award":["IITP-2026-RS-2022-00156389"],"award-info":[{"award-number":["IITP-2026-RS-2022-00156389"]}]},{"name":"Regional Innovation System & Education (RISE) Glocal 30 Program through the Daegu RISE Center","award":["2025-RISE-03-001"],"award-info":[{"award-number":["2025-RISE-03-001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45175-z","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:15:06Z","timestamp":1780319706000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An artificial intelligence model for prediction of hepatocellular carcinoma risk in patients with chronic hepatitis C"],"prefix":"10.1038","volume":"16","author":[{"given":"Yu Rim","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunyeol","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Young","family":"Tak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Oh","family":"Kweon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonjun","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungsang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"45175_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71, 209\u2013249 (2021).","journal-title":"CA Cancer J Clin"},{"key":"45175_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1148\/radiol.2017162756","volume":"287","author":"XL Xu","year":"2018","unstructured":"Xu, X. L., Liu, X. D., Liang, M. & Luo, B. M. Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: Systematic review of randomized controlled trials with meta-analysis and trial sequential analysis. Radiology 287, 461\u2013472 (2018).","journal-title":"Radiology"},{"key":"45175_CR3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3350\/cmh.2023.0099","volume":"29","author":"Y Cho","year":"2023","unstructured":"Cho, Y., Kim, B. H. & Park, J. W. Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison. Clin. Mol. Hepatol. 29, 252\u2013262 (2023).","journal-title":"Clin. Mol. Hepatol."},{"key":"45175_CR4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1053\/j.gastro.2016.09.009","volume":"152","author":"P Nahon","year":"2017","unstructured":"Nahon, P. et al. Eradication of Hepatitis C virus infection in patients with cirrhosis reduces risk of liver and non-liver complications. Gastroenterology 152, 142-156.e142 (2017).","journal-title":"Gastroenterology"},{"key":"45175_CR5","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.jhep.2017.07.025","volume":"67","author":"R Waziry","year":"2017","unstructured":"Waziry, R. et al. Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression. J. Hepatol. 67, 1204\u20131212 (2017).","journal-title":"J. Hepatol."},{"key":"45175_CR6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J. Hepatol. 69, 182\u2013236 (2018).","journal-title":"J. Hepatol."},{"key":"45175_CR7","unstructured":"Bhattacharya, D., Aronsohn, A., Price, J. & Lo Re, V. Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Clin Infect Dis (2023)."},{"key":"45175_CR8","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.jhep.2018.07.018","volume":"69","author":"JH Kim","year":"2018","unstructured":"Kim, J. H. et al. Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy. J. Hepatol. 69, 1066\u20131073 (2018).","journal-title":"J. Hepatol."},{"key":"45175_CR9","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1111\/liv.14666","volume":"40","author":"G Shiha","year":"2020","unstructured":"Shiha, G. et al. GES: A validated simple score to predict the risk of HCC in patients with HCV-GT4-associated advanced liver fibrosis after oral antivirals. Liver Int 40, 2828\u20132833 (2020).","journal-title":"Liver Int"},{"key":"45175_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/jgh3.12690","volume":"6","author":"T Tada","year":"2022","unstructured":"Tada, T. et al. A validation study of after direct-acting antivirals recommendation for surveillance score for the development of hepatocellular carcinoma in patients with hepatitis C virus infection who had received direct-acting antiviral therapy and achieved sustained virological response. JGH Open 6, 20\u201328 (2022).","journal-title":"JGH Open"},{"key":"45175_CR11","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1111\/apt.16632","volume":"54","author":"Y Tahata","year":"2021","unstructured":"Tahata, Y. et al. Prediction model for hepatocellular carcinoma occurrence in patients with hepatitis C in the era of direct-acting anti-virals. Aliment. Pharmacol. Ther. 54, 1340\u20131349 (2021).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"45175_CR12","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/hep4.1833","volume":"6","author":"N Tamaki","year":"2022","unstructured":"Tamaki, N. et al. Hepatocellular carcinoma risk assessment for patients with advanced fibrosis after eradication of Hepatitis C virus. Hepatol. Commun. 6, 461\u2013472 (2022).","journal-title":"Hepatol. Commun."},{"key":"45175_CR13","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.cgh.2023.11.005","volume":"22","author":"H Lin","year":"2024","unstructured":"Lin, H. et al. A liver stiffness-based etiology-independent machine learning algorithm to predict hepatocellular carcinoma. Clin. Gastroenterol. Hepatol. 22, 602-610.e607 (2024).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"45175_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jhep.2021.09.025","volume":"76","author":"HY Kim","year":"2022","unstructured":"Kim, H. Y. et al. An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B. J Hepatol 76, 311\u2013318 (2022).","journal-title":"J Hepatol"},{"key":"45175_CR15","unstructured":"Minami, T., et al. Machine learning for individualized prediction of hepatocellular carcinoma development after the eradication of hepatitis C virus with antivirals. J. Hepatol. (2023)."},{"key":"45175_CR16","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1186\/s12885-023-11628-1","volume":"23","author":"Y Zou","year":"2023","unstructured":"Zou, Y. et al. Accurate prediction of HCC risk after SVR in patients with hepatitis C cirrhosis based on longitudinal data. BMC Cancer 23, 1147 (2023).","journal-title":"BMC Cancer"},{"key":"45175_CR17","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jhep.2015.11.035","volume":"64","author":"G Papatheodoridis","year":"2016","unstructured":"Papatheodoridis, G. et al. PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy. J. Hepatol. 64, 800\u2013806 (2016).","journal-title":"J. Hepatol."},{"key":"45175_CR18","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3350\/cmh.2016.0086","volume":"23","author":"W Sohn","year":"2017","unstructured":"Sohn, W. et al. Risk score model for the development of hepatocellular carcinoma in treatment-na\u00efve patients receiving oral antiviral treatment for chronic hepatitis B. Clin. Mol. Hepatol. 23, 170\u2013178 (2017).","journal-title":"Clin. Mol. Hepatol."},{"key":"45175_CR19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jhep.2018.02.032","volume":"69","author":"YC Hsu","year":"2018","unstructured":"Hsu, Y. C. et al. Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B. J. Hepatol. 69, 278\u2013285 (2018).","journal-title":"J. Hepatol."},{"key":"45175_CR20","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/MEG.0000000000001357","volume":"31","author":"JH Yu","year":"2019","unstructured":"Yu, J. H. et al. Prediction model for hepatocellular carcinoma risk in treatment-naive chronic hepatitis B patients receiving entecavir\/tenofovir. Eur. J. Gastroenterol. Hepatol. 31, 865\u2013872 (2019).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"45175_CR21","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(18)32111-1","volume":"393","author":"F Carrat","year":"2019","unstructured":"Carrat, F. et al. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: A prospective cohort study. Lancet (London, England) 393, 1453\u20131464 (2019).","journal-title":"Lancet (London, England)"},{"key":"45175_CR22","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.jhep.2020.07.025","volume":"73","author":"R Fan","year":"2020","unstructured":"Fan, R. et al. aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis. J. Hepatol. 73, 1368\u20131378 (2020).","journal-title":"J. Hepatol."},{"key":"45175_CR23","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.jhep.2021.11.025","volume":"76","author":"G Semmler","year":"2022","unstructured":"Semmler, G. et al. HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease. J. Hepatol. 76, 812\u2013821 (2022).","journal-title":"J. Hepatol."},{"key":"45175_CR24","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai, C. T. et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38, 518\u2013526 (2003).","journal-title":"Hepatology"},{"key":"45175_CR25","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling, R. K. et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 43, 1317\u20131325 (2006).","journal-title":"Hepatology"},{"key":"45175_CR26","doi-asserted-by":"publisher","first-page":"18131","DOI":"10.3748\/wjg.v20.i48.18131","volume":"20","author":"M Soresi","year":"2014","unstructured":"Soresi, M., Giannitrapani, L., Cervello, M., Licata, A. & Montalto, G. Non invasive tools for the diagnosis of liver cirrhosis. World J. Gastroenterol. 20, 18131\u201318150 (2014).","journal-title":"World J. Gastroenterol."},{"key":"45175_CR27","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1111\/liv.14675","volume":"40","author":"S Yamamura","year":"2020","unstructured":"Yamamura, S. et al. MAFLD identifies patients with significant hepatic fibrosis better than NAFLD. Liver Int. 40, 3018\u20133030 (2020).","journal-title":"Liver Int."},{"key":"45175_CR28","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.jhep.2019.10.005","volume":"72","author":"M Pons","year":"2020","unstructured":"Pons, M. et al. Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals. J. Hepatol. 72, 472\u2013480 (2020).","journal-title":"J. Hepatol."},{"key":"45175_CR29","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","volume":"78","author":"AG Singal","year":"2023","unstructured":"Singal, A. G. et al. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology 78, 1922\u20131965 (2023).","journal-title":"Hepatology"},{"key":"45175_CR30","unstructured":"Hastie, T., Tibshirani, R. & Friedman, J. The Elements of Statistical Learning: Data Mining, Inference, and Prediction (Springer, 2017)."},{"key":"45175_CR31","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1111\/liv.15597","volume":"43","author":"HW Lee","year":"2023","unstructured":"Lee, H. W. et al. A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B. Liver Int. 43, 1813\u20131821 (2023).","journal-title":"Liver Int."},{"key":"45175_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2020.105551","volume":"196","author":"S Hashem","year":"2020","unstructured":"Hashem, S. et al. Machine learning prediction models for diagnosing hepatocellular carcinoma with HCV-related chronic liver disease. Comput. Methods Programs Biomed. 196, 105551 (2020).","journal-title":"Comput. Methods Programs Biomed."},{"key":"45175_CR33","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.bbe.2022.06.007","volume":"42","author":"Y Liu","year":"2022","unstructured":"Liu, Y., Liu, Z., Luo, X. & Zhao, H. Diagnosis of Parkinson\u2019s disease based on SHAP value feature selection. Biocybern. Biomed. Eng. 42, 856\u2013869 (2022).","journal-title":"Biocybern. Biomed. Eng."},{"key":"45175_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jhep.2022.01.027","volume":"77","author":"PP Mueller","year":"2022","unstructured":"Mueller, P. P. et al. Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradication. J. Hepatol. 77, 55\u201362 (2022).","journal-title":"J. Hepatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45175-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45175-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45175-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:05:54Z","timestamp":1786536354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45175-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45175"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45175-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"24989"}}